Qualigen Therapeutics, Inc. Reports Year-End 2021 Financial Results

Go back to Qualigen Therapeutics, Inc. Reports Year-End 2021 Financial Results
(NASDAQ: QLGN) Delayed: 3.21 --0 (-0%)
Previous Close $3.21    52 Week High
Open $3.21    52 Week Low
Day High $3.21    P/E N/A 
Day Low $3.21    EPS
Volume 14,490